• Journals
  • Why Publish With Us?
  • Editorial Policies
  • Author Guidelines
  • Peer Review Guidelines
  • Open Outlook
  • Hot topics
  • Podcasts
  • Blog
  • Reprints
  • Submit New Manuscript
Menu
  • About
  • Contact
  • Sustainability
  • Awards
  • Press Center
  • Testimonials
  • Blog
  • Favored Author Program
  • Permissions
  • Pre-Submission
  • Reprints
  • Login
  • Chinese website (中文网站)

open access to scientific and medical research

Advanced search
  • Home
  • Journals
  • Why publish with us?
  • Editorial Policies
  • Author Information
  • Peer Review Guidelines
  • Open Outlook
  • Hot topics
  • Podcasts

79900

Papers Published

Submit New Manuscript
Login to view existing manuscript status
Signup for Journal alerts

About Dove Press

Open access peer-reviewed scientific and medical journals.

Learn more

Open Access

Dove Medical Press is a member of the OAI.

Learn more

Reprints

Bulk reprints for the pharmaceutical industry.

Learn more

Favored Authors

We offer real benefits to our authors, including fast-track processing of papers.

Learn more

Promotional Article Monitoring

Register your specific details and specific drugs of interest and we will match the information you provide to articles from our extensive database and email PDF copies to you promptly.

Learn more

Social Media
     

Back to User profile » Dr Ann Childress

Papers published by Dr Ann Childress:


Original Research

The Effect of Viloxazine Extended-Release Capsules on Functional Impairments Associated with Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents in Four Phase 3 Placebo-Controlled Trials

Nasser A, Hull JT, Liranso T, Busse GD, Melyan Z, Childress AC, Lopez FA, Rubin J

Neuropsychiatric Disease and Treatment 2021, 17:1751-1762

Published Date: 3 June 2021

Review

A critical appraisal of atomoxetine in the management of ADHD

Childress AC

Therapeutics and Clinical Risk Management 2016, 12:27-39

Published Date: 23 December 2015

Original Research

Analysis of individual items on the attention-deficit/hyperactivity disorder symptom rating scale in children and adults: the effects of age and sex in pivotal trials of lisdexamfetamine dimesylate

Weisler RH, Adler LA, Kollins SH, Goodman DW, Hamdani M, Dirks B, Childress AC

Neuropsychiatric Disease and Treatment 2014, 10:1-12

Published Date: 9 December 2013

Original Research

Physician perception of clinical improvement in children with attention-deficit/hyperactivity disorder: a post hoc comparison of lisdexamfetamine dimesylate and mixed amphetamine salts extended release in a crossover analog classroom study

López F, Scheckner B, Childress A

Neuropsychiatric Disease and Treatment 2011, 7:267-273

Published Date: 6 May 2011

Contact Us   •  Privacy Policy   •  Associations & Partners   •  Testimonials   •  Terms & Conditions   •  Recommend this site •  Top

Contact Us  •  Privacy Policy

© Copyright 2023  •  Dove Press Ltd   •  software development by maffey.com • Web Design by Adhesion

The opinions expressed in all articles published here are those of the specific author(s), and do not necessarily reflect the views of Dove Medical Press Ltd or any of its employees.

Dove Medical Press is part of Taylor & Francis Group, the Academic Publishing Division of Informa PLC
Copyright 2017 Informa PLC. All rights reserved. This site is owned and operated by Informa PLC ( “Informa”) whose registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36


Accept

In order to provide our website visitors and registered users with a service tailored to their individual preferences we use cookies to analyse visitor traffic and personalise content. You can learn about our use of cookies by reading our Privacy Policy. We also retain data in relation to our visitors and registered users for internal purposes and for sharing information with our business partners. You can learn about what data of yours we retain, how it is processed, who it is shared with and your right to have your data deleted by reading our Privacy Policy.

If you agree to our use of cookies and the contents of our Privacy Policy please click 'accept'.